Palvella Therapeutics
PVLA
NASDAQ
IPO2024
about PVLA
Palvella Therapeutics is a biotechnology company focused on developing innovative gene therapy treatments for rare and life-threatening genetic disorders.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $113.00 | $127.69 | $109.00 | $1.0B | 1.20M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$1.03 | n/a | 2109.17 | -1620.54% | -1806.53% | 0% |